Examining the protective effects of acetyl l-carnitine on cisplatin-induced uterine tube toxicity
dc.contributor.author | Saribas G.S. | |
dc.contributor.author | Erdogan D. | |
dc.contributor.author | Goktas G. | |
dc.contributor.author | Akyol S.N. | |
dc.contributor.author | Hirfanoglu I.M. | |
dc.contributor.author | Gurgen S.G. | |
dc.contributor.author | Coskun N. | |
dc.contributor.author | Ozogul C. | |
dc.date.accessioned | 2025-04-10T11:09:00Z | |
dc.date.available | 2025-04-10T11:09:00Z | |
dc.date.issued | 2016 | |
dc.description.abstract | The aim of this study was to investigate the effects of cisplatin and the protective role of acetyl l-carnitine against uterine tube toxicity. Twenty-four female Wistar albino rats were divided into four groups: control group was injected with saline (control); group 2 was injected with acetyl l-carnitine; group 3 was injected with cisplatin; and group 4 was pre-treated with acetyl l-carnitine before cisplatin intraperitoneal injection. According to our results, a significant weight loss was observed in rats from group 3. The thickness of the wall and epithelium of uterine tube were decreased in group 3 rats. We elaborate the protein expression of caspase in epithelium and stroma by IHC. We found that the expression of caspase and the number of TUNEL-positive cells were increased in group 3 rats compared to the other groups. In our study, we showed the protective role of acetyl l-carnitine against uterine tube toxicity caused by cisplatin. © 2016 Informa UK Limited, trading as Taylor & Francis Group. | |
dc.identifier.DOI-ID | 10.1080/01443615.2016.1209174 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/48421 | |
dc.publisher | Taylor and Francis Ltd | |
dc.title | Examining the protective effects of acetyl l-carnitine on cisplatin-induced uterine tube toxicity | |
dc.type | Article |